التفاصيل البيبلوغرافية
| العنوان: |
Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: the mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study |
| المؤلفون: |
Eriksson, Jan W., Jansson, Per-Anders, Carlberg, Bo, Hägg, Anders, Kurland, Lisa, 1960, Svensson, Maria K., Ahlström, Håkan, Ström, Conny, Lönn, Lars, Öjbrandt, Kristina, Johansson, Lars, Lind, Lars |
| المصدر: |
Hypertension. 52(6):1030-1037 |
| مصطلحات موضوعية: |
insulin resistance, visceral obesity, liver fat, glucose clamp, magnetic resonance |
| الوصف: |
Treatment with angiotensin II receptor blockers is associated with lower risk for the development of type 2 diabetes mellitus compared with thiazide diuretics. The Mechanisms for the Diabetes Preventing Effect of Candesartan Study addressed insulin action and secretion and body fat distribution after treatment with candesartan, hydrochlorothiazide, and placebo. Twenty-six nondiabetic, abdominally obese, hypertensive patients were included in a multicenter 3-way crossover trial, and 22 completers (by predefined criteria; 10 men and 12 women) were included in the analyses. They underwent 12-week treatment periods with candesartan (C; 16 to 32 mg), hydrochlorothiazide (H; 25 to 50 mg), and placebo (P), respectively, and the treatment order was randomly assigned and double blinded. Intravenous glucose tolerance tests and euglycemic hyperinsulinemic (56 mU/m(2) per minute) clamps were performed. Intrahepatic and intramyocellular and extramyocellular lipid content and subcutaneous and visceral abdominal adipose tissue were measured using proton magnetic resonance spectroscopy and MRI. Insulin sensitivity (M-value) was reduced following H versus C and P (6.07+/-2.05, 6.63+/-2.04, and 6.90+/-2.10 mg/kg of body weight per minute, mean+/-SD; P
|
| وصف الملف: |
print |
| URL الوصول: |
https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-69404 |
| قاعدة البيانات: |
SwePub |